Events​

Upcoming events in the life science industry

BiotechX Europe 2024Basel, Switzerland

BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. With 16 tracks of high-level content and a poster presentation session, the event covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data. In 2024 BioTechX will return to Basel, the pharma hub of Europe, this time with 3500 global executives, 400 speakers and 50 start-ups all under one roof, bridging the gap between pharma, academia and clinicians. Don't miss Europe's largest biotechnology congress for pharma, healthcare and partners. For 50% off delegate tickets, use code BTG50 Free VIP guest link for Biotechgate members that fall into the buy side part of the conference

Delegates from Venture Valuation and Biotechgate will attend the event
AusBioInvest 2024Melbourne, Australia

Connecting innovators with investors, the 18th annual AusBioInvest conference will be held on Tuesday 29 October in Melbourne, Australia. AusBioInvest, Australia’s premier life science investment conference, is dedicated to building meaningful connection between investors and private and publicly-listed biotech companies actively seeking investors or partners to support their funding and co-development. The full-day programme will feature keynotes and panel sessions with leading investors and business leaders on the trends, themes, and market conditions shaping life science investing, in addition to up to 25 presentations from early to late-stage biotechnology companies seeking investment and strategic partners. Investors also receive access to an exclusive networking lounge and AusPartnering, AusBiotech’s 1:1 business matching programme. Qualified investors are invited to register for a complimentary pass here »

Delegates from Venture Valuation and Biotechgate will attend the event
BioFuture 2024New York City, USA

BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.

Delegates from Venture Valuation and Biotechgate will attend the event
AusBiotech 2024 National ConferenceMelbourne, Australia

Step into the future of biotechnology at AusBiotech 2024, Australia’s largest life science conference, held in Melbourne from 30 October – 1 November. AusBiotech 2024 features an industry-led programme with more than 170 speakers across over 60 sessions developed to inform, educate, celebrate, and inspire the life science community. AusBiotech 2024 is created by industry, for industry. This year's programme features a one-day AgriBiotech Summit, the Early-Stage Innovation Forum rapid-fire pitch competition, conference gala dinner, and plenty of formal and informal networking opportunities. For over 38 years, the AusBiotech conference has been the premier international meeting place for the Australian life science community, attracting delegates from over 20 countries. Learn from international and local thought leaders as they discuss the latest research, technologies, challenges, opportunities, and market access strategies. Engage in in-person networking, cutting-edge programming, and be part of advancing the life sciences industry during the flagship event of ‘Australia’s biggest week in biotech’. Register here »

Delegates from Venture Valuation and Biotechgate will attend the event
BIO-Europe® 2024Stockholm, Sweden

The 30th annual BIO-Europe will take place November 4-6, 2024 in Stockholm, Sweden, and it will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event. Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward. BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programmes, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.

Delegates from Venture Valuation and Biotechgate will attend the event
Pre-JPM Partnering WeekOnline

Prepare for JPM 2025 success. Biotechgate and Big4Bio are hosting a special edition of Biotechgate Digital Partnering. The conference is designed to provide virtual business development opportunities to Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with workshops, panel discussions and informal networking.

Delegates from Venture Valuation and Biotechgate will attend the event
RESI JPM 2025San Francisco, USA

The 43rd JPM Healthcare Conference 2025 will be held at the Westin St. Francis in San Francisco from January 13-16, 2025. As the industry’s largest and most comprehensive healthcare investment symposium, it will attract tens of thousands of life science professionals from around the world. Concurrently, the 50th RESI Conference will be held on January 14 with in-person conference, followed by two days of online partnership events. Previous RESI JPM conferences have attracted over a thousand attendees, including more than 500 early-stage life science investors and licensing partners, an equal number of life science innovators, and many industry experts.

Delegates from Venture Valuation and Biotechgate will attend the event